Astrana Health, Inc. (ASTH) Stock Grade

About Astrana Health, Inc.'s fundamentals

Astrana Health demonstrates strong revenue expansion with 56.4% year-over-year growth, indicating robust demand for its healthcare services. However, the company operates with minimal profitability, generating a net margin of just 0.7% despite its significant top-line growth, suggesting thin operating efficiency or substantial reinvestment in growth. At a P/E ratio of 54.2, the stock reflects elevated valuation relative to current earnings, while the return on equity of 2.9% indicates limited efficiency in generating profits from shareholder capital. The company offers minimal shareholder income through dividends, with a yield of just 0.2%.